Capital Raise Board Consents in the UK: What Founders Need to Approve

When a funding round starts moving quickly, founders often focus on valuation, investor appetite and getting the term sheet signed. The corporate approvals can get left behind until the last minute. That is where problems start. A board meeting that was never properly called, directors voting despite conflicts, or shares being issued without checking the company’s articles can all create avoidable risk just when investors are doing diligence.

Capital raise board consents are the formal company approvals that let a fundraising proceed properly. They help show that directors considered the deal, approved the transaction on the right terms and authorised the practical steps needed to complete it. They also create a paper trail for future investors, acquirers and anyone reviewing the company records later.

This guide explains what founders in the UK usually need to approve, when board consents become necessary, and the common mistakes that slow down a raise or create clean-up work after completion. If you are about to issue shares, approve investor documents or update your cap table before you sign, these are the approvals to get right.

Overview

Capital raise board consents are the board resolutions and related corporate approvals used to approve a fundraising, issue shares and authorise the directors or officers to complete the deal documents. The exact package depends on your company’s articles, shareholders’ agreement, the type of round and whether shareholder approvals are also needed.

• Check whether the board can approve the raise on its own, or whether shareholder consent is also required.
• Review the articles of association, any shareholders’ agreement and existing investor rights before agreeing terms.
• Confirm the directors have authority to allot shares and whether pre-emption rights apply or need to be disapplied.
• Prepare accurate board minutes or written resolutions that approve the investment documents and the share issue.
• Deal with conflicts of interest properly, especially where founder directors are participating in the round or have side arrangements.
• Make sure Companies House filings, statutory registers and share certificates are updated after completion.

What Capital Raise Board Consents Means For UK Businesses

For a UK company, capital raise board consents usually mean a formal board decision approving the fundraising and the mechanics needed to implement it. That often includes approving subscription or investment documents, authorising the allotment of shares, approving any changes to the articles, and authorising someone to sign and file the necessary paperwork.

Most startups raising external investment use a private limited company. In that structure, directors manage the company, but their powers are not unlimited. The articles of association, the Companies Act 2006 and any shareholders’ agreement may require certain decisions to go to shareholders, either by ordinary or special resolution.

This is why founders cannot assume that a signed term sheet is enough. A term sheet is usually only the commercial starting point. The company still needs to approve the actual transaction in line with its governance documents.

What the board is usually approving

The board consent pack for a capital raise often covers several separate approvals. The exact list changes depending on the round, but it commonly includes:

• approval of the fundraising itself and confirmation that it is in the company’s best interests
• approval of the final form of subscription agreement, investment agreement or other transaction documents
• approval of any new articles of association to be adopted on completion
• approval of the allotment and issue of shares, including the number, class and price
• authority for one or more directors to sign documents and complete the transaction
• authority to update the company’s statutory books, issue share certificates and make Companies House filings

In a simple friends and family raise, the paperwork may be fairly light. In a seed or venture round, the consent package is often broader because the raise may include investor consent rights, warranties, a new share class, EMI option pool changes or reserved matters.

Board consent is not the same as shareholder consent

This distinction catches founders out regularly. The directors may approve entering into the transaction, but the shareholders may still need to authorise or ratify certain steps. A few common examples are:

• granting directors authority to allot shares under section 551 of the Companies Act 2006, unless an exemption applies
• disapplying statutory pre-emption rights under section 570, if relevant and not already dealt with in the articles
• adopting new articles of association by special resolution
• approving matters reserved to shareholders under a shareholders’ agreement

Private companies often rely on pre-existing shareholder authorities in the articles or earlier resolutions, but that should never be assumed. Before you sign a contract, check what authority is already in place and whether it covers this specific raise.

Why investors care about the paperwork

Investors are not asking for board minutes just to create admin. They want evidence that the company has issued shares validly and followed its own rules. If the approvals are defective, the investor may worry about title to the shares, future disputes, or a messy diligence process in the next round.

The same issue matters later if the company is sold. A buyer reviewing historic fundraising steps will want to see that each allotment was properly authorised, recorded and filed. Missing board consents can lead to delays, extra warranties, or requests for rectification work before completion.

Directors still owe duties during a raise

Directors cannot treat a fundraising as purely procedural. They still need to act in accordance with their duties under the Companies Act 2006. In plain English, they should consider the company’s interests, exercise independent judgment and avoid undisclosed conflicts.

This matters especially where founder directors are negotiating terms that affect them personally, such as vesting changes, service agreement updates, preference share rights or secondary sales. The board minutes should reflect that conflicts were considered and dealt with under the articles and any shareholders’ agreement.

When This Issue Comes Up

Capital raise board consents come up any time your company is taking in new equity investment or changing its capital structure as part of a funding. The need is not limited to a large venture round. Even relatively small raises can require formal approvals.

At pre-seed and seed stage

This is often the first point where founder-led informality stops working. A company that started with two directors and a basic cap table may suddenly be issuing ordinary shares, preference shares or convertible instruments to outside investors. The legal documents become more detailed, and so do the approval requirements.

Common founder moments include:

• friends and family investing before you spend money on company setup or product build
• an angel round where one investor wants information rights or board observer rights
• a seed raise where new articles and investor protections are being introduced

When issuing shares after a term sheet

Once heads of terms or a term sheet are agreed, many founders assume completion is just paperwork. In practice, this is where the consent process usually bites. The company has to approve the deal documents in final form, confirm authority to allot the agreed shares and satisfy any conditions precedent.

If those steps are left until the day funds are due to arrive, the raise can stall. Investors may hold off wiring money until the approvals and ancillary documents are complete.

When existing rights affect the new round

The issue often becomes more complicated after your first institutional investor comes in. Earlier investment documents may contain:

• investor consent rights over new share issues
• anti-dilution or pre-emption arrangements
• special approval thresholds for amending articles
• reserved matters that need consent from a class of shareholders

This is where founders often get caught. They focus on new money coming in, but forget that legacy documents may give existing investors a say before the company can proceed.

When using convertible instruments or SAFEs

Not every capital raise involves an immediate share issue. If the company is using convertible loan notes or a UK-style SAFE, the board still usually needs to approve entering into the instrument. The board should also understand what happens on conversion, including who has authority to issue shares later and whether further shareholder approvals will be needed at that stage.

A future conversion can create the same problems as a direct equity round if the company did not plan ahead on allotment authority and pre-emption.

When cleaning up records before due diligence

Sometimes the issue comes up because a new investor asks to see historic approvals and the company realises its records are incomplete. Board consents may need to be reconstructed carefully, but backdating or trying to invent a paper trail is not the answer. If records are missing, the company should work out what can properly be ratified, corrected or documented now, with advice where needed.

Practical Steps And Common Mistakes

The safest approach is to treat the corporate approvals as part of the deal process from the start, not as admin to tidy up at the end. Founders who do this early usually avoid last-minute signing issues and investor concerns.

1. Review your governance documents early

Before you sign a contract or spend money on completion mechanics, pull together the current constitutional and governance documents. At a minimum, review:

• the articles of association
• any shareholders’ agreement or investment agreement already in place
• past shareholder resolutions granting allotment authority or disapplying pre-emption rights
• the cap table and details of existing share classes

This tells you who actually has to approve the new raise. It also helps you spot whether the proposed round needs a new share class, a variation of class rights or an amendment to the articles.

2. Check authority to allot shares

One of the most important technical points is whether the directors have authority to allot the new shares. In many private companies, the directors need authority under section 551 of the Companies Act 2006 unless a statutory exemption applies. For some private companies with only one class of shares, the rules may work differently, but this should be checked carefully against the company’s position.

If the authority is missing or too narrow, shareholder approval may be needed before the allotment can happen validly. This is not something to leave until after funds arrive.

3. Deal with pre-emption rights properly

Pre-emption rights can apply under statute, the articles or a shareholders’ agreement. In broad terms, they may require new shares to be offered to existing shareholders first, or they may require specific procedures before an allotment to outsiders.

Founders sometimes assume pre-emption rights do not matter because all shareholders support the round commercially. The legal process may still need to be followed. Depending on the setup, this could involve:

• obtaining a shareholder resolution disapplying statutory pre-emption rights
• following contractual offer procedures under a shareholders’ agreement
• getting written waivers from relevant shareholders

If this point is missed, the allotment may be challenged and the fundraising timetable can unravel.

4. Identify director conflicts before the meeting

A capital raise often affects directors personally. Founder directors may subscribe for shares, negotiate employment contracts or service agreement updates, or benefit from option pool changes. Some articles allow conflicted directors to count in the quorum or vote in certain circumstances, while others restrict this unless the conflict is authorised.

The board papers should identify known conflicts and the meeting should be run accordingly. That may include disclosures before the meeting, noting who participated, or having non-conflicted directors approve certain matters where required.

5. Approve the actual documents, not vague placeholders

Board minutes should refer to the final or near-final transaction documents, not a rough idea of the deal. If the documents are materially different from what the board approved, the board may need to reconvene or pass updated written resolutions.

This matters where terms move at the last minute, such as valuation changes, investor rights, liquidation preferences or conditions attached to completion. A clean approval record should match the deal that was actually signed.

6. Make the board minutes useful

Good board minutes do not need to be overly long, but they should show real decision-making. They should usually record:

• the date, attendees and whether a quorum was present
• any conflicts disclosed and how they were handled
• what documents were tabled or reviewed
• the board’s decision to approve the transaction and why it considered it to be in the company’s interests
• who was authorised to sign, complete and file the relevant documents

Minutes that are too thin can look careless. Minutes that say things happened which did not happen can be worse. Accuracy matters more than formality for its own sake.

7. Do the post-completion housekeeping

The board consents are only part of the job. After completion, the company still needs to update its records and deal with filing requirements. Depending on the round, that may include:

• updating the register of members and other statutory registers
• issuing share certificates within the required timeframe
• filing the return of allotment at Companies House
• filing amended articles if new articles were adopted
• updating the cap table and internal investor records

This stage gets missed more often than founders expect. The main risk is that the legal position and the company’s records drift apart, which creates trouble in later diligence.

Common mistakes founders make

A few problems come up repeatedly in UK raises:

• signing the investment documents before the right approvals are in place
• using old template minutes that do not match the company’s articles or the actual transaction
• forgetting that shareholder consent is separate from board approval
• ignoring conflict rules because all directors are aligned commercially
• issuing shares and taking funds but delaying Companies House filings and statutory register updates
• treating a convertible instrument as if no corporate approvals are needed until conversion

These issues are usually fixable, but clean-up often costs more and takes longer than getting the process right first time.

A practical example

Suppose a UK tech startup with three founder shareholders agrees a seed round with an angel syndicate. The investors want preference shares, new articles and a small employee option pool increase. One founder is also putting in extra money personally.

The company may need board approval of the investment documents, shareholder approval to adopt new articles, confirmation of authority to allot the new share class, a pre-emption analysis, and proper handling of the founder director’s personal participation. After completion, the company will need to issue share certificates, update the registers and make the relevant filings.

None of that is unusual. It is exactly the kind of deal where founders can save time by sorting the consents alongside the transaction documents, not after signatures are already circulating.

FAQs

Do all UK fundraising rounds need board consent?

In most cases, yes. If a company is entering into investment documents, issuing shares or approving related corporate actions, the board will usually need to approve those steps formally. The exact form may be board minutes or written resolutions, depending on the circumstances.

Is board approval enough to issue new shares?

Not always. The company may also need shareholder approval for allotment authority, pre-emption disapplication, adopting new articles or complying with reserved matters in a shareholders’ agreement.

Can directors vote if they are investing in the round?

Sometimes, but not automatically. It depends on the company’s articles, the nature of the conflict and whether the conflict has been properly disclosed or authorised. This should be checked before the meeting takes place.

What happens if the company missed a board consent in an earlier round?

The company should review what was actually approved, what records exist and whether corrective action is possible. The right fix depends on the facts. Backdating documents is not the answer, and a proper clean-up process may be needed.

Do convertible loan notes or SAFEs need board approval?

Usually yes. Even if shares are not being issued immediately, the company is still entering into a financing arrangement and should approve the instrument properly. It should also plan for the approvals that may be needed on conversion.

Key Takeaways

• Capital raise board consents are the formal company approvals that allow a fundraising to proceed properly and help show the shares were validly issued.
• Founders should check the articles, any shareholders’ agreement, allotment authority and pre-emption rights before agreeing to complete a round.
• Board approval and shareholder approval are different, and many raises need both.
• Conflicts of interest should be identified and managed properly, especially where founder directors are personally involved in the transaction.
• Accurate board minutes, signed resolutions, Companies House filings and updated statutory registers all matter for future diligence.
• Sorting the consent process early is usually far easier than fixing missing approvals after funds have been received.

If your business is dealing with capital raise board consents and wants help with board minutes, shareholder resolutions, share issue approvals, and Companies House filings, you can reach us on 08081347754 or team@sprintlaw.co.uk for a free, no-obligations chat.